𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tonsillectomy in post-transplant lymphoproliferative disease in children

✍ Scribed by Angela K. Sturm-O'Brien; M. John Hicks; Carla M. Giannoni; Marcelle Sulek; Ellen M. Friedman


Book ID
102451121
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
70 KB
Volume
120
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objectives/Hypothesis:

To review the role of tonsillectomy in diagnosis and management of post‐transplant lymphoproliferative disorder (PTLD).

Study Design:

Case series using a retrospective chart review.

Methods:

A retrospective review of post‐transplant lymphoproliferative disease at a tertiary academic medical center from January 2004 to April 2008. Data extracted includes patients' gender, age at transplantation, year of transplantation and tonsillectomy, type of transplant, presenting symptoms, type of immunosuppression, and outcome.

Results:

Six out of 25 (24%) patients who underwent tonsillectomy were found to have PTLD. The patient's characteristics, gender, age at transplantation, year of transplantation and tonsillectomy, type of transplant, presenting symptoms, type of immunosuppression, and outcomes are discussed.

Conclusions:

In our series, tonsillar hypertrophy, male gender, young age at transplantation, and liver transplantation were associated with higher rates of PTLD. Given the devastating nature of PTLD, early detection with tonsillectomy and institution of treatment is critical. Laryngoscope, 2010


πŸ“œ SIMILAR VOLUMES


Subcutaneous implantation of human post-
✍ Parmjeet S. Randhawa; Beatta Pietrzak; Michael A. Nalesnik; Anthony Jake Demetri πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

The tumorigenic potential of six post-transplant B-cell lymphoproliferative disease (PTLD) lesions was evaluated in SCID mice. Three animals developed local subcutaneous B cell tumours, two of which contained Epstein-Barr virus (EBV) DNA. Two animals developed CD3 positive thymic neoplasms, and one